You are here: Industry Insights > trial

News List

Trovagene Initiates Enrollment for KRAS-Mutated Colorectal Cancer Trial americanpharmaceuticalreview
July 10, 2019
Trovagene announced the initiation of patient enrollment of its Phase 1b/2 study of onvansertib in combination with FOLFIRI and Avastin® (bevacizumab) for second-line treatment of patients with metastatic colorectal cancer (mCRC) with a KRAS mutation (NCT
Dermata Therapeutics Announces Positive Results from DMT410 Trial americanpharmaceuticalreview
July 10, 2019
Dermata Therapeutics has announced positive results from a Phase 1 POC clinical trial of DMT410 (DMT310 + botulinum toxin (BTX)) for the treatment of primary axillary hyperhidrosis.
Cellect Biotechnology, Washington University Finalize Accelerated Clinical Trial Agreement americanpharmaceuticalreview
July 09, 2019
As the two organizations move closer to the commencement of the clinical trial to determine the safety and tolerability of the Apograft technology for bone marrow transplantations ...
First Participant Enrolled in Second Phase 3 Universal Flu Vaccine Trial americanpharmaceuticalreview
July 09, 2019
BiondVax Pharmaceuticals announced the first participants in the second cohort of the pivotal, clinical efficacy, Phase 3 trial of the M-001 universal flu vaccine candidate have been successfully enrolled.
Clinical trial sponsors called to publish results on EU database europeanpharmaceuticalreview
July 05, 2019
All sponsors of clinical trials conducted in the European Union have been reminded of their obligation to make summaries of trial results.
Report suggests process for vaccine trials during health crises europeanpharmaceuticalreview
July 04, 2019
A recent report has presented an argument for updating vaccine development during health emergencies to increase efficiency.
Bioinvent Receives IND Approval for Phase I/iia Trial of Anti-fcyriib Antibody americanpharmaceuticalreview
July 04, 2019
BioInvent has received authorization from the U.S. Food and Drug Administration (FDA) to proceed with an Investigational New Drug (IND) application for a Phase I/IIa clinical trial of an immune-modulatory anti-FcγRllB antibody in combination with an anti-
Lilly's Trial Studying Higher Doses of Trulicity® (dulaglutide) Meets Primary Endpoint americanpharmaceuticalreview
June 28, 2019
Eli Lilly and Company's trial studying higher investigational doses of Trulicity® (dulaglutide) met its primary efficacy endpoint of superiority
IMFINZI® Improves OS at Interim Analysis in CASPIAN Trial in Small Cell Lung Cancer americanpharmaceuticalreview
June 28, 2019
AstraZeneca announced positive overall survival (OS) results from the Phase III CASPIAN trial with IMFINZI in 1st-line extensive-stage small cell lung cancer (SCLC), a disease with significant unmet need and limited treatment options for patients.
Cara Therapeutics Initiates Second Pruritus Phase 2 Trial of Peptelligence® americanpharmaceuticalreview
June 28, 2019
Enteris BioPharma congratulates Cara Therapeutics on the successful initiation of its Phase 2 clinical trial of Oral KORSUVA™ (CR845/difelikefalin) for the treatment of pruritus in patients with hepatic impairment due to primary biliary cholangitis (PBC).

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page